Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
141.50
+1.00 (0.71%)
Mar 24, 2026, 1:20 PM CST

TPEX:6712 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,018933.81758.39627.51438.84
Revenue Growth (YoY)
8.96%23.13%20.86%42.99%521.61%
Cost of Revenue
296.18273.77273.64212.96193.36
Gross Profit
721.33660.04484.75414.56245.48
Selling, General & Admin
44.2347.1847.9140.0745.14
Research & Development
238.16147.2299.1190.6984.14
Other Operating Expenses
-44.38---
Operating Expenses
282.33238.85147.02130.76129.28
Operating Income
439421.19337.73283.8116.2
Interest Expense
-0.92-0.13-0.2-0.51-0.62
Interest & Investment Income
27.9710.8914.189.886
Earnings From Equity Investments
-9.2552.09---
Currency Exchange Gain (Loss)
--21.76-30.72-
Other Non Operating Income (Expenses)
67.5323.37.527.354.27
EBT Excluding Unusual Items
524.33507.35380.99269.79125.85
Gain (Loss) on Sale of Investments
--46.68241.86-5.7261.05
Gain (Loss) on Sale of Assets
----011.33
Asset Writedown
-----1.94
Other Unusual Items
-0.080.170.010.52
Pretax Income
524.33460.74623.01264.1396.82
Income Tax Expense
94.993.4983.6263.3927.22
Net Income
429.43367.25539.4200.71369.6
Net Income to Common
429.43367.25539.4200.71369.6
Net Income Growth
16.93%-31.91%168.74%-45.69%-
Shares Outstanding (Basic)
8889909190
Shares Outstanding (Diluted)
8889909191
Shares Change (YoY)
-0.89%-1.65%-1.01%0.15%11.01%
EPS (Basic)
4.884.145.992.214.10
EPS (Diluted)
4.884.145.972.204.06
EPS Growth
17.98%-30.75%171.70%-45.83%-
Free Cash Flow
535.07435.49415.92316.02133.7
Free Cash Flow Per Share
6.084.914.613.461.47
Dividend Per Share
-4.6544.9591.5033.416
Dividend Growth
--6.15%229.89%-56.00%-
Gross Margin
70.89%70.68%63.92%66.06%55.94%
Operating Margin
43.14%45.11%44.53%45.23%26.48%
Profit Margin
42.20%39.33%71.12%31.99%84.22%
Free Cash Flow Margin
52.59%46.63%54.84%50.36%30.47%
EBITDA
462.17440.28357.69307.28141.47
EBITDA Margin
45.42%47.15%47.16%48.97%32.24%
D&A For EBITDA
23.1819.0919.9623.4825.27
EBIT
439421.19337.73283.8116.2
EBIT Margin
43.14%45.11%44.53%45.23%26.48%
Effective Tax Rate
18.10%20.29%13.42%24.00%6.86%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.